Physical activity and human islet amyloid polypeptide islet amyloidosis: mechanistic plausibility, missing evidence, and future directions
Endocrinology · 03.08.2026 · 167 (9)
DOI: 10.1210/endocr/bqag088 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Endocrinology, online erschienen am 04.08.2026. Verfasst von Joan-Marc Servitja und 2 weiteren Autor:innen. Beteiligte Einrichtung: Pathogenesis and Prevention of Diabetes Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain. Hauptthemen laut MEDLINE: Islet Amyloid Polypeptide, Amyloidosis, Diabetes Mellitus, Type 2, Exercise. Die Arbeit nennt 90 Literaturangaben.
Abstract (Originalsprache)
Islet amyloid deposition derived from human islet amyloid polypeptide (hIAPP, amylin) is a hallmark of type 2 diabetes (T2D) and is tightly linked to progressive β-cell dysfunction and loss. It is now well established that the “toxic oligomer” hypothesis, in which soluble or intracellular hIAPP assemblies contribute to β-cell proteotoxicity and to the amplification of inflammatory stress, coexists with fibril associated and inflammation-driven mechanisms of toxicity. Regular physical activity (PA) is a cornerstone of T2D management and improves insulin sensitivity, glycemic control, ectopic lipid handling, and systemic inflammation, all of which could reduce β-cell secretory burden and the cellular milieu that favors hIAPP misfolding. However, direct demonstrations that PA delays or reduces islet amyloid formation remain scarce. This gap largely reflects methodological constrains in quantifying amyloid dynamics in humans and the absence of exercise studies with amyloid-specific endpoints. Herein, we synthesize mechanistic links by which exercise could influence hIAPP aggregation propensity (β-cell workload, glucolipotoxicity, endoplasmic reticulum stress, mitochondrial function, and inflammatory signaling) and highlight proteostasis pathways, particularly autophagy/lysosomal clearance, which are experimentally shown to defend β-cells against hIAPP oligomer toxicity. Overall, while direct evidence remains sparse, substantial mechanistic plausibility supports a link between PA and hIAPP amyloid biology. Future studies incorporating amyloid-specific outcomes are needed to determine whether exercise directly modifies amyloid formation, reduces oligomer burden, or primarily enhances β-cell resilience to proteotoxic stress.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pathogenesis and Prevention of Diabetes Group, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona 08036, Spain.
- Centro de Investigación Biomédica en Red de Diabetes y Enfermedades Metabólicas Asociadas (CIBERDEM), Madrid, Spain.
- Facultat de Psicologia, Ciències de l'Educació i de l'Esport Blanquerna, Universitat Ramon Llull, Barcelona 08022, Spain.
- Facultat de Ciències de la Salut, Blanquerna, Universitat Ramon Llull, Barcelona 08025, Spain.
ORCID-Profile: Joan-Marc Servitja, Anna Novials, Joel Montane
Zitieren
APA
Servitja, J. M., Novials, A., & Montane, J. (2026). Physical activity and human islet amyloid polypeptide islet amyloidosis: mechanistic plausibility, missing evidence, and future directions. Endocrinology, 167(9). https://doi.org/10.1210/endocr/bqag088
Vancouver
Servitja JM, Novials A, Montane J. Physical activity and human islet amyloid polypeptide islet amyloidosis: mechanistic plausibility, missing evidence, and future directions. Endocrinology. 2026;167(9). doi:10.1210/endocr/bqag088
BibTeX
@article{Servitja2026,
author = {Servitja, Joan-Marc and Novials, Anna and Montane, Joel},
title = {Physical activity and human islet amyloid polypeptide islet amyloidosis: mechanistic plausibility, missing evidence, and future directions},
journal = {Endocrinology},
year = {2026},
volume = {167},
number = {9},
doi = {10.1210/endocr/bqag088}
}
EUVIMED